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Introduction {#s1}
============

Gastric cancer is one of the most common malignancy and the third leading cause of cancer death worldwide, with an estimated 952,000 new cases and 723,000 deaths occurred in 2012 [@pone.0109605-WHO1]. Although surgical resection is the mainstay of treatment for gastric cancer, overall 5-year relative survival rates for gastric cancer patients remain utterly gloomy with approximately 60% in Asian countries and 20% in western countries [@pone.0109605-Kamangar1]. It is well known that gastric cancer is a devastating and multifactorial disease, which derived from extremely complex interactions between genetic and environmental factors [@pone.0109605-Pharoah1]. Single Nucleotide Polymorphisms (SNPs) are the most common type of genetic variations and may contribute to an individual\'s susceptibility to cancer.

Chronic inflammation is well known to play a critical role in initiating and promoting several human cancers including gastric cancer. TLRs activation contributes significantly to the initiation and maintenance of inflammatory response, dysregulation of TLRs signaling may lead to an imbalance state between pro-inflammatory and anti-inflammatory cytokines, and then to an increased susceptibility to chronic inflammatory diseases and cancer [@pone.0109605-Achyut1]. Accumulated evidence has suggested that SNPs located in leucine-rich repeat(LRR) of TLRs may upregulate or downregulate the receptor response ability to bind ligand of pathogens which they normally recognize [@pone.0109605-Bell1]. Human TLR4 gene is located on chromosome 9q32-q33 and contains four exons. It is highly expressed on monocytes, lymphocytes and splenocytes. After binding with LPS or other ligands and conjunction with CD14 and myeloid differential protein-2 (MD-2), TLR4 could transduce relevant signals that promote transcription of immune-related genes, and thus activate and magnify subsequent immune response including NF-κB and MAPK signal pathways [@pone.0109605-Takeda1], [@pone.0109605-He1]. Many recent studies have demonstrated the critical role of TLR4 in the inflammatory-related immune response to H. Pylori infection in the pathogenesis of gastric cancer. TLR4 polymorphisms allow H. Pylori to elude attack from the host innate immune cell, and to survival in gastric epithelium for a long time, leading to chronic inflammation and causing severe gastritis, hypochlorhydria, gastric atrophy, intestinal metaplasia and dysplasia, which are precancerous lesions of gastric cancer [@pone.0109605-ElOmar1]--[@pone.0109605-Kato1].

Many SNPs in TLR4 have been detected and studied, but two of the most typical SNPs in the fourth exon of coding sequence, +896A/G (ID: rs4986790) and +1196C/T (ID: rs4986791), were explored and reported extensively for the gastric cancer susceptibility [@pone.0109605-ElOmar1], [@pone.0109605-Zou1], [@pone.0109605-Zhang1]. To date, several studies focused on the association of TLR4 (+896A/G and +1196C/T) polymorphisms with precancerous lesions, gastric cancer, across different ethnicities [@pone.0109605-Zou1]--[@pone.0109605-Santini1], however, due to the limitations of subjects, the results were inconsistent and controversial. For example, there were two meta-analyses investigating the correlation between TLR4 +896A/G polymorphism and cancer risk, but the results remained partly conflicting [@pone.0109605-Zhang1], [@pone.0109605-Jing1]. The clinical heterogeneity derived from included studies on diverse histological types of cancers might affect the reliability and stability of the overall results. In addition, the previous meta-analyses did not cover all eligible publications related to gastric cancer and thus decreased the efficacy and probability of detecting the authentic association between TLR4 gene polymorphisms and gastric cancer risk. To clarify and quantify the authentic effect of TLR4 (+896A/G and +1196C/T) polymorphisms on susceptibility to gastric cancer, we performed a meta-analysis including all eligible case-control studies. As far as we know, this was the most comprehensive meta-analysis concerning this subject. All potential genetic models [@pone.0109605-Zhu1] and publication bias detection methods were used in our meta-analysis, which made the results more robust and reliable.

Materials and Methods {#s2}
=====================

Identification and eligibility of relevant studies {#s2a}
--------------------------------------------------

A systematic search was conducted using the PubMed and EMBase databases (last search was updated on March 26 2014), with the following search details: TLR4 \[All Fields\] AND ("polymorphism, genetic" \[MeSH Terms\] OR ("polymorphism" \[All Fields\] AND "genetic" \[All Fields\]) OR "genetic polymorphism" \[All Fields\] OR "polymorphism" \[All Fields\]) AND ("stomach neoplasms" \[MeSH Terms\] OR ("stomach" \[All Fields\] AND "neoplasms" \[All Fields\]) OR "stomach neoplasms" \[All Fields\] OR ("gastric" \[All Fields\] AND "cancer" \[All Fields\]) OR "gastric cancer" \[All Fields\]). With the purpose of identifying the extra eligible studies, the references cited in the publications or review articles concerning this topic were manually searched too. Our search was limited to English-language articles. The identified studies in our meta-analysis met the following criteria: (1) studies investigating the association of TLR4 polymorphisms (+896A/G or +1196C/T) with gastric cancer risk; (2) case-control studies and studies included available genotype frequencies; (3) inclusion of comprehensive data to calculate odds ratio (OR) and 95% confidence interval (CI); (4) publications with full-text article. Major criteria for excluding studies were: (1) precancerous lesions or benign tumors; (2) without control subjects; (3) duplicated previous publications; (4) the control subjects did not meet the Hardy-Weinberg Equilibrium (HWE). At last, 10 case-control published studies from PubMed and EMbase were available, including a total of 1888 gastric cancer patients and 3433 control subjects for the TLR4 polymorphisms (+896A/G and +1196C/T). The PRISMA checklist was available as supplementary material, as displayed in [Checklist S1](#pone.0109605.s001){ref-type="supplementary-material"}.

Data extraction {#s2b}
---------------

Two investigators (QZ and CCW) performed the data extraction independently, and then conducted consensus decision to resolve the disagreements. All study personnel were blinded throughout the meta-analysis. For each study, the following information was collected: the name of first author, publication year, country, ethnicity, design, genotyping method, number of cases and controls, genotype and allele frequencies for cases and controls, and HWE of controls.

Meta-analysis {#s2c}
-------------

The HWE was recalculated in the present meta-analysis according to the HWE principle and formula [@pone.0109605-Ward1]. And a *P*-value more than 0.05 was considered to meet HWE. Meta-analysis for TLR4 polymorphisms was performed by using the software Stata 12.0 (Stata Corporation, College Station, TX, USA). The association of the TLR4 polymorphisms (+896A/G and +1196C/T) with risk of gastric cancer was estimated by odds ratios (OR) and 95% confidence intervals (CI). The significance of pooled OR was measured by the Z-test, and statistical significance was determined as a 2-sided *P*-value less than 0.05. We measured the association of allele G and allele T (additive model) with gastric cancer risk, and made comparisons with heterozygous model (AG vs. AA) and (CT vs. CC). Heterogeneity assumption was conducted with a χ^2^-based Q-test. If the *P*-value\>0.05 for Q-test, thus demonstrating that all studies were lack of heterogeneity, then fixed effect model was adopted to merge studies (the Mantel-Haenszel method) [@pone.0109605-Mantel1], or else the random effect model (the DerSimonian and Laird method) was used [@pone.0109605-DerSimonian1]. Subgroup meta-analyses according to different races (Caucasian and non-Caucasian) have been conducted based on these genetic models. In addition, sensitivity analysis was conducted to evaluate stability of the results by excluding one study at a time, the pooled ORs were recalculated to assess the altered effect of individual study on the overall results. Furthermore, potential publication bias was diagnosed and measured by using the Begg and Mazumdar rank correlation test [@pone.0109605-Begg1] and Funnel plots and Egger\'s regression test [@pone.0109605-Egger1].

Results {#s3}
=======

Characteristics of eligible studies {#s3a}
-----------------------------------

A total of 41 studies were identified by using different combinations of MeSH terms on PubMed and EMbase. According to the inclusion and exclusion criteria, 10 case-control studies that consisted of a total of 1888 gastric cancer patients and 3433 control subjects were included in this meta-analysis [@pone.0109605-Companioni1], [@pone.0109605-Santini1], [@pone.0109605-Egger1]--[@pone.0109605-Kutikhin1]. Literature search strategy and included or excluded studies were presented in [Figure 1](#pone-0109605-g001){ref-type="fig"}. Detailed information, such as author name, publication year, region, ethnicity, design, genotyping method, numbers about cases and controls were summarized in [Table 1](#pone-0109605-t001){ref-type="table"}. The publication year of eligible studies ranged from 2007 to 2014. Two studies adopted hospital-based control, while the other eight studies adopted population-based control. All cases diagnosed with gastric cancer were also validated by pathological examination. All of them adopted blood samples for genotyping. All quality scores of selected articles were higher than 25 (moderate-high quality) [@pone.0109605-daCosta1]. The results of HWE test in the control population and genotype frequencies of TLR4 +896A/G and +1196C/T polymorphisms were recalculated and extracted from all eligible publications, and were shown in [Table 2](#pone-0109605-t002){ref-type="table"}. All the eligible studies met the HWE (all *P*\>0.05).

![Flow diagram of included and excluded studies.](pone.0109605.g001){#pone-0109605-g001}

10.1371/journal.pone.0109605.t001

###### Characteristics of studies included in the meta-analysis.

![](pone.0109605.t001){#pone-0109605-t001-1}

  Study name                  Region   Ethnicity   Design     Genotyping     Case   Control
  -------------------------- -------- ----------- -------- ---------------- ------ ---------
  TLR4(+896A/G,rs4986790)                                                          
  Santini(2008)               Italy    Caucasian     PB        PCR-RFLP      171      151
  Rigoli(2010)                Italy    Caucasian     PB        PCR-RFLP       60      87
  Trejo-de la(2008)           Mexico    Mexican      HB     PCR-sequencing    38      144
  de Oliveira(2012)           Brazil   Caucasian     PB        PCR-RFLP      174      225
  Hold(2007)a                  USA     Caucasian     PB        PCR-RFLP      307      211
  Hold(2007)b                 Poland   Caucasian     PB        PCR-RFLP      312      419
  Garza-Gonzalez(2007)        Mexico    Mexican      HB        PCR-RFLP       78      189
  Companioni(2014)            Italy    Caucasian     PB     PCR-sequencing   361     1270
  de Oliveira(2013)           Brazil   Caucasian     PB        PCR-RFLP      200      240
  Qadri(2013)                 India      Asian       PB        PCR-RFLP      130      200
  Kutikhin(2014)              Russia   Caucasian     PB         Taqman        57      297
  TLR4(+1196C/T,rs4986791)                                                         
  Garza-Gonzalez(2007)        Mexico    Mexican      HB        PCR-RFLP       78      156
  Santini(2008)               Italy    Caucasian     PB        PCR-RFLP      171      151
  Rigoli(2010)                Italy    Caucasian     PB        PCR-RFLP       70      87
  Trejo-de la(2008)           Mexico    Mexican      HB     PCR-sequencing    61      202
  de Oliveira(2012)           Brazil   Caucasian     PB        PCR-RFLP      174      225
  Companioni(2014)            Italy    Caucasian     PB         Taqman       354     1263
  de Oliveira(2013)           Brazil   Caucasian     PB        PCR-RFLP      200      240
  Qadri(2013)                 India      Asian       PB        PCR-RFLP      130      200
  Kutikhin(2014)              Russia   Caucasian     PB         Taqman        66      300

HB: hospital based, PB: population based, PCR-RFLP: polymerase chain reaction-restriction fragment length polymorphism.

10.1371/journal.pone.0109605.t002

###### The distribution of the TLR4 +896A/G and +1196C/T polymorphisms in gastric cancer.

![](pone.0109605.t002){#pone-0109605-t002-2}

                              Case(n)   Control(n)                                                     
  -------------------------- --------- ------------ ---- ----- ---- -------- ----- ---- -------- ----- ------
  TLR4(+896A/G, rs4986790)                                                                             
  Santini(2008)                 159         11       1    329   13    140     11    0     291     11    0.64
  Rigoli(2010)                  42          18       0    102   18     80      7    0     167      7    0.7
  Trejo-de la(2008)             34          4        0    72    4     138      6    0     282      6    0.18
  de Oliveira(2012)             154         20       0    328   20    215     10    0     440     10    0.7
  Hold(2007)a                   266         38       3    570   44    196     16    1     408     18    0.29
  Hold(2007)b                   258         51       3    567   57    387     31    1     805     33    0.65
  Garza-Gonzalez(2007)          72          6        0    150   6     175     14    0     364     14    0.6
  Companioni(2014)              316         45       0    677   45   \#\#\#   133   3    \#\#\#   139   0.66
  de Oliveira(2013)             174         26       0    374   26    224     16    0     464     16    0.59
  Qadri(2013)                   107         23       0    237   23    169     31    0     369     31    0.23
  Kutikhin(2014)                46          11       0    103   11    258     39    0     555     39    0.23
                              Case(n)   Control(n)                                                     
  TLR4(+1196C/T,rs4986791)      CC          CT       TT    C    T      CC     CT    TT     C       T   
  Garza-Gonzalez(2007)          77          1        0    155   1     179     10    0     368     10    0.71
  Santini(2008)                 155         15       1    325   17    147      4    0     298      4    0.87
  Rigoli(2010)                  57          13       0    127   13     81      6    0     168      6    0.74
  Trejo-de la(2008)             57          4        0    118   4     193      9    0     395      9    0.75
  de Oliveira(2012)             165         9        0    339   9     219      6    0     444      6    0.84
  Companioni(2014)              309         45       0    663   45   \#\#\#   134   5    \#\#\#   144   0.64
  de Oliveira(2013)             191         9        0    391   9     234      6    0     474      6    0.84
  Qadri(2013)                   114         16       0    244   16    182     18    0     382     18    0.51
  Kutikhin(2014)                55          11       0    121   11    255     45    0     555     45    0.16

HWE: Hardy-Weinberg Equilibrium.

Quantitative data synthesis {#s3b}
---------------------------

The overall frequency of G allele in TLR4 +896A/G polymorphism was 7% in cases and 5% in controls. The frequency of the T allele in TLR4 +1196C/T polymorphism was 5% in cases and 4% in controls. For TLR4 +896A/G polymorphism, individuals carrying the variant AG genotype had a significantly increased gastric cancer risk compared with the AA genotype (heterozygous model) (AG vs. AA: OR = 1.67, 95%CI = 1.39--2.01, *P* = 0.000) ([Figure 2A](#pone-0109605-g002){ref-type="fig"}). The significance also have been detected in the additive model for the comparison of G allele with A allele (G vs. A: OR = 1.64, 95%CI = 1.37--1.95, *P* = 0.000) ([Figure 2B](#pone-0109605-g002){ref-type="fig"}). Moreover, for TLR4 +1196C/T polymorphism, an increased gastric cancer risk was found for the comparison of CT with CC genotype (heterozygous model) (CT vs. CC: OR = 1.42, 95%CI = 1.11--1.81, *P* = 0.005) ([Figure 2C](#pone-0109605-g002){ref-type="fig"}), as well as for the comparison of T allele with C allele (additive model) (T vs. C: OR = 1.36, 95%CI = 1.08--1.72, *P* = 0.010) ([Figure 2D](#pone-0109605-g002){ref-type="fig"}). Besides, subgroup meta-analyses according to different races (Caucasian and non-Caucasian) have been conducted based on these genetic models. We found significantly positive correlations between the two selected TLR4 polymorphisms and increased risks of gastric cancer in Caucasians, but not in non-Caucasian. The significant association of dominant model (AG+GG vs. AA: OR = 1.68, 95%CI = 1.40--2.02, *P* = 0.000 and CT+TT vs. CC: OR = 1.40, 95%CI = 1.10--1.78, *P* = 0.006) with gastric cancer risk was also observed. In all genetic comparisons, fixed effect model (Mantel-Haenszel method) was used as a result of no obvious heterogeneity (Q-test: *P*\>0.05, I^2^\<50%) ([Table 3](#pone-0109605-t003){ref-type="table"}). However, there was no significant difference in homozygous model (GG vs. AA and TT vs.CC) or recessive model (GG vs. AG+AA and TT vs. CT+TT). There were two studies investigating the association between TLR4 +896A/G polymorphism and H. Pylori infection in gastric cancer patients [@pone.0109605-Hold1], [@pone.0109605-Qadri1], and one study for TLR4 +1196C/T polymorphism [@pone.0109605-Qadri1]. However, no significant association was observed in the overall results, TLR4 +896A/G polymorphism did not increase the risk of H. Pylori infection in gastric cancer patients ([Figure 3A:](#pone-0109605-g003){ref-type="fig"} AG vs. AA, [Figure 3B:](#pone-0109605-g003){ref-type="fig"} G vs. A).

![Forest plots showing the association of the TLR4 +896A/G and +1196C/T polymorphisms with risk of gastric cancer.\
A. AG vs. AA; B. G vs. A; C. CT vs. CC; D. T vs. C.](pone.0109605.g002){#pone-0109605-g002}

![Forest plots showing the association of the TLR4 +896A/G polymorphism with H. Pylori infection in gastric cancer patients.\
A. AG vs. AA, B. G vs. A.](pone.0109605.g003){#pone-0109605-g003}

10.1371/journal.pone.0109605.t003

###### The results of Q-test in all genetic models for TLR4 +896A/G and +1196C/T polymorphisms in gastric cancer.

![](pone.0109605.t003){#pone-0109605-t003-3}

  Genotype         Q-value   I-squared(%)   P-value      OR(95%CI)       Pooled P-value
  --------------- --------- -------------- --------- ------------------ ----------------
  TLR4 +896A/G                                                          
  AG vs. AA         17.55         43         0.063    1.67(1.39--2.01)         0
  GG+AG vs. AA      18.02        44.5        0.055    1.68(1.40--2.02)         0
  G vs. A           17.43        42.6        0.065    1.64(1.37--1.95)         0
  TLR4 +1196C/T                                                         
  CT vs. CC         9.36         14.5        0.313    1.42(1.11--1.81)       0.005
  TT+CT vs. CC      10.13         21         0.256    1.40(1.10--1.78)       0.006
  T vs. C           10.71        25.3        0.219    1.36(1.08--1.72)        0.01

Sensitivity analysis {#s3c}
--------------------

We conducted sensitivity analysis to evaluate the root of heterogeneity. There was no heterogeneity in heterozygous, dominant models and additive models in TLR4 +896A/G and TLR4 +1196C/T polymorphisms. Besides, no single study qualitatively affected the pooled OR, as demonstrated by sensitivity analysis ([Figure 4](#pone-0109605-g004){ref-type="fig"}), which suggested that the results of this meta-analysis are reliable and stable. However, there was significant heterogeneity in homozygous and recessive model because that the homozygous genotype GG and TT in many studies were absent.

![Sensitivity analysis for heterogeneity.\
A. AG vs. AA; B. G vs. A; C. CT vs. CC; D. T vs. C.](pone.0109605.g004){#pone-0109605-g004}

Publication bias {#s3d}
----------------

Publication bias within each study might not represent all studies. We performed Begg\'s funnel plot and Egger\'s linear regression test to assess the publication bias of all included studies. As demonstrated in [Figure 5](#pone-0109605-g005){ref-type="fig"}, the funnel plots did not display any evidence of obvious asymmetry under the heterozygous and additive models ([Figure 5A](#pone-0109605-g005){ref-type="fig"}. AG vs. AA: z = 0.78, *P* = 0.436; [Figure 5B](#pone-0109605-g005){ref-type="fig"}. G vs. A: z = 0.78, *P* = 0.436; [Figure 5C](#pone-0109605-g005){ref-type="fig"}. CT vs. CC: z = 0.52, *P* = 0.602; [Figure 5D](#pone-0109605-g005){ref-type="fig"}. T vs. C: z = 0.730, *P* = 0.466). Egger\'s test also suggested that there was no obvious statistical publication bias under the heterozygous and additive models ([Figure 6A](#pone-0109605-g006){ref-type="fig"}. AG vs. AA: t = 0.97, *P* = 0.358; [Figure 6B](#pone-0109605-g006){ref-type="fig"}. G vs. A: t = 1.05, *P* = 0.322; [Figure 6C](#pone-0109605-g006){ref-type="fig"}. CT vs. CC: t = 0.71, *P* = 0.501; [Figure 6D](#pone-0109605-g006){ref-type="fig"}. T vs. C: t = 0.97, *P* = 0.365).

![Begg\'s funnel plots for publication bias test.\
A. AG vs. AA; B. G vs. A; C. CT vs. CC; D. T vs. C.](pone.0109605.g005){#pone-0109605-g005}

![Egger\'s linear regression plots for publication bias test.\
A. AG vs. AA; B. G vs. A; C. CT vs. CC; D. T vs. C.](pone.0109605.g006){#pone-0109605-g006}

Discussion {#s4}
==========

Extensive genetic and epidemiological evidence indicates that chronic inflammation imposes great risk for the development and progression of many kinds of cancers [@pone.0109605-Cole1], [@pone.0109605-Kazma1], especially for gastric cancer [@pone.0109605-Bornschein1], [@pone.0109605-Wang1]. TLR4 plays a pivotal role in innate immunity defending the body against pathogenic organisms. The recognition of TLR4 by its ligand results in a cascade reaction including the IL-1R family activation and followed by the activation of NF-κB [@pone.0109605-Aderem1], which is a key mediator of inflammation-induced gastric cancer development [@pone.0109605-He1], [@pone.0109605-Huang1]. However, the function of TLR4 at the protein level will be impaired by SNPs in TLR4 gene, subsequently leading to an altered susceptibility to chronic inflammatory diseases and cancers [@pone.0109605-Armant1], [@pone.0109605-Liew1]. The causal link between H. Pylori and gastric cancer has been confirmed. Recent studies have revealed that SNPs within TLR4 is significantly associated with gastric chronic-inflammation and HP infection related mucosa lesions [@pone.0109605-Kato1], [@pone.0109605-Schmausser1]--[@pone.0109605-Bagheri1]. Several SNPs within TLR4 have been identified, and the two commonest (+896A/G and +1196C/T) of them that were founded in the fourth exon of coding sequence affect the stability of TLR4 extracellular domain and result in adenine-guanine (A--G) and cytosine-thymine (C--T) exchanges, respectively, and thus finally cause amino acid substitutions: glycine for aspartic at position 299 and isoleucine for threonine at position 399 [@pone.0109605-Arbour1], [@pone.0109605-Mockenhaupt1]. Wild-type TLR4 possesses a particular area with negative charge at position 299, which is absent in +896A/G polymorphism, and thus such polymorphism enhances the rotational freedom and angle of the peptide bond in the LPS/MD-2 complex binding area [@pone.0109605-Rallabhandi1]. Consequently, the interaction of TLR4 with LPS may be modulated by the altered rotation and charge, which results in the functional peculiarities of target cells with +896A/G polymorphism [@pone.0109605-Ferwerda1]. As opposed to +896A/G polymorphism, the branched side chain is conserved in +1196C/T polymorphism, however, the increased three-dimensional bulk in this region, probably preventing ligands or cofactors from docking [@pone.0109605-Rallabhandi1]. Both +896A/G and +1196C/T TLR4 polymorphisms may result in the loss of docking, which cannot be precluded by the remaining functional interactions, and it is verified by the fact that the targeted doubly mutated TLR4 molecule permanently responds more poorly to the stimulation of ligand than TLR4 molecules that possess either the +896A/G or +1196C/T mutation [@pone.0109605-Rallabhandi1]. Individuals with TLR4 polymorphisms possess an increased susceptibility to severe gastric inflammation, hypochlorhydria, gastric atrophy and subsequent development of intestinal metaplasia [@pone.0109605-ElOmar1], [@pone.0109605-Fan1], which the latter two are considered as the most critical precancerous pathological changes associated with gastric cancer.

Although the important role of TLR4 polymorphisms in the development of gastric cancer has been reported in recent years, the results are inconsistent. Garza-Gonzalez et al reported that there was no correlation between TLR4 polymorphisms and gastric cancer in Mexican ethnicity [@pone.0109605-GarzaGonzalez1], however, Trejo-de la et al insisted that both SNPs (+896A/G and +1196C/T) within TLR4 had an increased susceptibility to gastro-duodenal diseases including duodenal ulcer and gastric cancer [@pone.0109605-Trejodela1]. Other studies suggested that only one of these two polymorphisms (either +1196C/T or +896A/G) had association with an increased risk of precancerous lesions and gastric cancer [@pone.0109605-Achyut1], [@pone.0109605-Santini1]. Hold et al indicated that TLR4 +896A/G polymorphism was associated with increased susceptibility to gastric atrophy and subsequent gastric carcinogenesis [@pone.0109605-Hold1]. Recently, several studies have shown that both +896A/G and +1196C/T SNPs were related to increased gastric cancer risk [@pone.0109605-Companioni1], [@pone.0109605-Qadri1], [@pone.0109605-Kutikhin1], while de Oliveira et al has shown not +1196C/T but +896A/G to be associated with such an increased risk in a Brazilian population [@pone.0109605-deOliveira1]. Consequently, we performed a comprehensive meta-analysis on the correlation between the TLR4 polymorphisms (+896A/G and +1196C/T) and gastric cancer risk. As far as we know, this was the most comprehensive and updated meta-analysis investigating the association between TLR4 polymorphisms and gastric cancer risk. Because the studies involving in our meta-analysis completely met all the screening criteria, the results from these pooled studies were more powerful than those from single study. After searching the PubMed and EMbase, a total of 10 case-control studies were available including 1888 gastric cancer patients and 3433 control subjects from 2007 to 2014. Consistent with the conclusions resulted from the mentioned studies, our results demonstrate that both +896A/G and +1196C/T TLR4 polymorphisms are associated with a significantly increased gastric cancer, especially for genotype model (heterozygous: AG vs. AA, dominant: GG+AG vs. AA, heterozygous: CT vs. CC, dominant: CT+TT vs. CC) and additive model (G vs. A and T vs. C). Therefore, these two polymorphisms should be regarded as the most significant polymorphisms in TLR4. In the overall +896A/G and +1196C/T meta-analyses, we demonstrated that the minor alleles could obviously increase the risk of gastric cancer in comparison with major alleles, showing that these two genetic variants may critically modify the susceptibility to gastric cancer. In the subgroup meta-analyses, we found significantly positive correlations between the two selected TLR4 polymorphisms and increased risks of gastric cancer in Caucasians, but not in non-Caucasian. The discrepancy between the two races may be attributed to the differences of life styles and diverse environmental exposure factors of the different ethnic populations.

However, there are several limitations of the current meta-analysis, which must be taken into consideration. Because the homozygous genotypes of TLR4 gene (GG and TT) were almost completely absent in the population studied, homozygous and recessive models were absent in the present study. To reconfirm this result, more cases about comprehensive population (Western countries and Asian countries) should be included in the study on the association of TLR4 SNPs with gastric cancer. In addition, articles in other languages (not English) were excluded, which may deviate the results. Besides, subgroup analysis according to gastric cancer site (cardia and noncardia) and histological type, and risk factor analysis for different precancerous lesions according to its type, could provide us more valuable information, but the sample size and individual original data limitations hinder a statistically significant analysis. Finally, TLRs induce the expression of pro-inflammatory genes on gastric mucosa, and the interactions between environmental carcinogens (biologic, chemical and physical stimulations) and host cells, that could be used to elucidate the mechanism by which TLR4 +896A/G and +1196C/T polymorphisms increase risk of developing gastric cancer. More original data need to be obtained to interpret the gene-environment interactions and subsequent gastric carcinogenesis.

In conclusion, this meta-analysis demonstrates that TLR4 +896A/G and +1196C/T polymorphisms probably increase the susceptibility to gastric cancer mainly in Caucasians, while the susceptibility to gastric cancer in Chinese and other Asian population need to be proved in future large scale studies. Although genome-wide association studies (GWAS) are important procedures for the discovery of genetic variations and the reliability of meta-analysis, there are no available previous GWAS on this subject, thus, we have performed sensitivity analysis and publication bias test to avoid such potential discrepancy in this meta-analysis, which suggests no obvious selection bias and confirms the reliability and stability of our results. Since gastric cancer is a multifactorial and multistep disease, it is important to perform well-design and large scale studies, including comprehensive individual data, homogenous patients and underlying source population based controls, standardized genotyping methods to thoroughly reveal the association of TLR4 polymorphisms with gastric cancer risk.

Supporting Information {#s5}
======================

###### 

**PRISMA meta-analysis checklist.**

(DOCX)

###### 

Click here for additional data file.

We thank all the people who helped in this study.

[^1]: **Competing Interests:**The authors have declared that no competing interests exist.

[^2]: Conceived and designed the experiments: LPS BYL. Performed the experiments: QZ CCW. Analyzed the data: QZ CCW XFW XYW. Contributed reagents/materials/analysis tools: QZ CCW XFW XYW. Wrote the paper: QZ LPS. Reviewed the manuscript: ZGZ BYL.
